全文获取类型
收费全文 | 17401篇 |
免费 | 2180篇 |
国内免费 | 652篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 495篇 |
妇产科学 | 147篇 |
基础医学 | 4110篇 |
口腔科学 | 271篇 |
临床医学 | 1399篇 |
内科学 | 3146篇 |
皮肤病学 | 361篇 |
神经病学 | 651篇 |
特种医学 | 253篇 |
外国民族医学 | 3篇 |
外科学 | 1364篇 |
综合类 | 2505篇 |
现状与发展 | 11篇 |
预防医学 | 1049篇 |
眼科学 | 265篇 |
药学 | 1460篇 |
8篇 | |
中国医学 | 1078篇 |
肿瘤学 | 1593篇 |
出版年
2024年 | 72篇 |
2023年 | 573篇 |
2022年 | 653篇 |
2021年 | 1336篇 |
2020年 | 994篇 |
2019年 | 824篇 |
2018年 | 719篇 |
2017年 | 848篇 |
2016年 | 823篇 |
2015年 | 743篇 |
2014年 | 964篇 |
2013年 | 1312篇 |
2012年 | 843篇 |
2011年 | 834篇 |
2010年 | 752篇 |
2009年 | 675篇 |
2008年 | 630篇 |
2007年 | 650篇 |
2006年 | 630篇 |
2005年 | 548篇 |
2004年 | 492篇 |
2003年 | 421篇 |
2002年 | 420篇 |
2001年 | 403篇 |
2000年 | 312篇 |
1999年 | 266篇 |
1998年 | 253篇 |
1997年 | 214篇 |
1996年 | 199篇 |
1995年 | 192篇 |
1994年 | 175篇 |
1993年 | 136篇 |
1992年 | 130篇 |
1991年 | 153篇 |
1990年 | 97篇 |
1989年 | 87篇 |
1988年 | 92篇 |
1987年 | 115篇 |
1986年 | 90篇 |
1985年 | 108篇 |
1984年 | 110篇 |
1983年 | 67篇 |
1982年 | 94篇 |
1981年 | 50篇 |
1980年 | 36篇 |
1979年 | 33篇 |
1978年 | 15篇 |
1977年 | 17篇 |
1976年 | 16篇 |
1973年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 375 毫秒
991.
《Pediatric neurology》2014,50(2):188-191
BackgroundIntravenous immunoglobulin is the favored therapy in childhood immune thrombocytopenic purpura. It is usually well tolerated with manageable side effects, but venous and arterial thrombosis following its administration have been described, mostly in adults.MethodsWe describe a 3-year-old girl with immune thrombocytopenic purpura and intracranial hemorrhage who received intravenous immunoglobulin therapy and subsequently developed multifocal cerebral infarctions.ResultsProduct specific as well as other factors may play a role in the development of this complication of intravenous immunoglobulin therapy. This is the only reported case of intravenous immunoglobulin–related thrombosis in a child with immune thrombocytopenic purpura and intracranial hemorrhage.ConclusionsThrombotic complications are associated with intravenous immunoglobulin administration and this includes cerebral infarcts. 相似文献
992.
Hiroya Kuwahara Kuniaki Tsuchiya Zen Kobayashi Akira Inaba Haruhiko Akiyama Hidehiro Mizusawa 《Neuropathology》2014,34(1):45-48
Cryptococcal meningitis is rarely complicated by immune‐mediated leukoencephalopathy, but the precise pathomechanism is uncertain. A 72‐year‐old Japanese man treated with prednisolone for Sweet disease developed a subacute progression of meningitis, which was considered as neuro‐Sweet disease. A treatment by methylprednisolone rapidly improved CSF findings with a remarkable decrease in lymphocyte numbers in the blood, but the patient's consciousness still worsened after the cessation of the treatment. The patient developed cryptococcal meningitis and MRI showed abnormal intensities predominantly in the cerebral deep white matter along with the recovery of lymphocyte numbers in the blood, which resulted in death. A postmortem examination of the brain revealed degenerative lesions, especially at the cerebral white matter and cortex adjacent to the leptomeninges abundantly infiltrated by Cryptococcus neoformans. In the affected cerebral deep white matter, perivascular infiltration of lymphocytes was prominent in coexistence with reactive astrocytes and vascular proliferation, but these findings were not observed in the subcortical and cortical lesions. Cryptococcus neoformans was not present within the brain parenchyma. This is the first report of a case suggesting that cryptococcal meningitis can accompany lymphocytic inflammation predominantly in cerebral deep white matter as a possible manifestation of immune reconstitution inflammatory syndrome. 相似文献
993.
Claire Bridel Judit Horvath Mary Kurian André Truffert Andreas Steck Patrice H. Lalive 《Journal of the peripheral nervous system : JPNS》2014,19(2):180-182
Multifocal motor neuropathy (MMN) and anti‐myelin‐associated glycoprotein (anti‐MAG)‐associated neuropathy are clinically and electrophysiologically distinct entities. We describe a patient with characteristic features of both neuropathies, raising the possibility of an overlap syndrome. A 49‐year‐old patient reported a history of slowly progressive predominantly distal tetraparesis, with mild sensory deficits. Nerve conduction studies demonstrated persistent motor conduction blocks outside compression sites, typical of MMN. Laboratory findings revealed persistently high titers of anti‐MAG immunoglobulin Mλ (IgMλ) paraprotein in the context of a monoclonal gammapathy of unknown significance. Skin biopsy of distal lower limb revealed IgM positive terminal nerve perineurium deposits. This case suggests that the distinction between subtypes of chronic inflammatory neuropathies may not be as clear as initially thought, and that the pattern of pathogenicity of anti‐MAG antibodies may vary. 相似文献
994.
Hannah X Chu Hyun Ah Kim Seyoung Lee Jeffrey P Moore Christopher T Chan Antony Vinh Mathias Gelderblom Thiruma V Arumugam Brad RS Broughton Grant R Drummond Christopher G Sobey 《Journal of cerebral blood flow and metabolism》2014,34(3):450-459
We tested whether significant leukocyte infiltration occurs in a mouse model of permanent cerebral ischemia. C57BL6/J male mice underwent either permanent (3 or 24 hours) or transient (1 or 2 hours+22- to 23-hour reperfusion) middle cerebral artery occlusion (MCAO). Using flow cytometry, we observed ∼15,000 leukocytes (CD45+high cells) in the ischemic hemisphere as early as 3 hours after permanent MCAO (pMCAO), comprising ∼40% lymphoid cells and ∼60% myeloid cells. Neutrophils were the predominant cell type entering the brain, and were increased to ∼5,000 as early as 3 hours after pMCAO. Several cell types (monocytes, macrophages, B lymphocytes, CD8+ T lymphocytes, and natural killer cells) were also increased at 3 hours to levels sustained for 24 hours, whereas others (CD4+ T cells, natural killer T cells, and dendritic cells) were unchanged at 3 hours, but were increased by 24 hours after pMCAO. Immunohistochemical analysis revealed that leukocytes typically had entered and widely dispersed throughout the parenchyma of the infarct within 3 hours. Moreover, compared with pMCAO, there were ∼50% fewer infiltrating leukocytes at 24 hours after transient MCAO (tMCAO), independent of infarct size. Microglial cell numbers were bilaterally increased in both models. These findings indicate that a profound infiltration of inflammatory cells occurs in the brain early after focal ischemia, especially without reperfusion. 相似文献
995.
996.
Marc Lúcia Elena Crespo Josep M. Cruzado Josep M. Grinyó Oriol Bestard 《Transplant international》2014,27(7):643-656
Despite the great efficacy of current antiviral preventive strategies, hCMV infection is still a major complication after renal transplantation, significantly challenging patient and graft survival. This issue seems to be explained because of the rather poor immunologic monitoring of the antiviral immune response. An important body of evidence has shown that monitoring the hCMV‐specific T‐cell response, at different time points of the transplant setting, seems to add crucial information for predicting the risk of viral infection, thus potentially helping individualization of therapeutic decision‐making in clinical transplantation. While several immune‐cellular assays have shown its capability for accurately monitoring hCMV‐specific T‐cell responses, only few such as the IFN‐γ ELISPOT and the ELISA based technology assays might be reliable for its application in the clinic. Nonetheless, an important effort has to be made among the transplant community to standardize and validate such immune assays. Noteworthy, large‐scale prospective randomized trials are highly warranted to ultimately introduce them in current clinical practice as a part of the highly desired personalized medicine. 相似文献
997.
Ildefonso Espigado Fátima de la Cruz‐Vicente Omar J. BenMarzouk‐Hidalgo Irene Gracia‐Ahufinger Jose R. Garcia‐Lozano Manuela Aguilar‐Guisado Jose M. Cisneros Alvaro Urbano‐Ispizua Pilar Perez‐Romero 《Transplant international》2014,27(12):1253-1262
The aim of this study was to characterize timing, kinetic, and magnitude of CMV‐specific immune response after hematopoietic stem cell transplantation (HSCT) and its ability to predict CMV replication and clinical outcomes. Using cell surface and intracellular cytokine staining by flow cytometry, CMV‐specific T‐cell response was measured in blood, while CMV viral load and chimerism were determined by real‐time PCR. Patients that reconstituted CMV‐specific T‐cell response within 6 weeks after Allo‐SCT showed a more robust immune response (CD8+: 0.7 cells/μl vs. 0.3/μl; P‐value = 0.01), less incidence of CMV replication (33% vs. 89.5%; P‐value = 0.007), reduced viral loads (1.81 log copies/ml vs. 0 copies/ml; P‐value = 0.04), and better overall survival (72%; CI: 0.53–0.96 vs. 42% CI: 0.24–0.71; P‐value = 0.07) than patients with a delayed immune reconstitution. Viremic patients had significantly higher transplant‐related mortality than nonviremic patients after 1 year (33% CI: 0.15–0.52 vs. 0% CI: 0.05–0.34; P‐value = 0.01). Risk factors independently associated with viral replication were receptor pretransplant CMV‐positive serostatus (P‐value = 0.02) and acquiring CMV‐specific T‐cell response after 6 weeks post‐transplantation (P‐value = 0.009). In conclusion, timing of acquiring a positive CMV‐specific T‐cell immune response after transplantation may identify patients with different risk for viral replication and different clinical outcomes, including survival. 相似文献
998.
The natural food contaminants, mycotoxins, are regarded as an important risk factor for human and animal health, as up to 25% of the world’s crop production may be contaminated. The Fusarium genus produces large quantities of fusariotoxins, among which the trichothecenes are considered as a ubiquitous problem worldwide. The gastrointestinal tract is the first physiological barrier against food contaminants, as well as the first target for these toxicants. An increasing number of studies suggest that intestinal epithelial cells are targets for deoxynivalenol (DON) and other Type B trichothecenes (TCTB). In humans, various adverse digestive symptoms are observed on acute exposure, and in animals, these toxins induce pathological lesions, including necrosis of the intestinal epithelium. They affect the integrity of the intestinal epithelium through alterations in cell morphology and differentiation and in the barrier function. Moreover, DON and TCTB modulate the activity of intestinal epithelium in its role in immune responsiveness. TCTB affect cytokine production by intestinal or immune cells and are supposed to interfere with the cross-talk between epithelial cells and other intestinal immune cells. This review summarizes our current knowledge of the effects of DON and other TCTB on the intestine. 相似文献
999.
M. A. ElTanbouly E. Schaafsma R. J. Noelle J. L. Lines 《Clinical and experimental immunology》2020,200(2):120-130
The immune response is governed by a highly complex set of interactions among cells and mediators. T cells may be rendered dysfunctional by the presence of high levels of antigen in the absence of co-stimulation while myeloid cells may be programmed towards an immunosuppressive state that promotes cancer growth and metastasis while deterring tumor immunity. In addition, inhibitory programs driven by immune checkpoint regulators dampen anti-tumor immunity. The ideal cancer immunotherapy treatment will improve both cross-priming in the tumor microenvironment and relieve suppression by the inhibitory checkpoints. Recently, blockade of programmed cell death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) has elicited impressive results, but not in all patients, so additional targets are under investigation. V-set immunoglobulin domain suppressor of T cell activation (VISTA) is a novel immunoregulatory receptor that is broadly expressed on cells of the myeloid and lymphoid lineages, and is frequently implicated as a poor prognostic indicator in multiple cancers. Importantly, antibody targeting of VISTA uniquely engages both innate and adaptive immunity. This, combined with the expression of VISTA and its non-redundant activities compared to other immune checkpoint regulators, qualifies VISTA to be a promising target for improving cancer immunotherapy. 相似文献
1000.